{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:57:19Z","timestamp":1792547839797,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.intimp.2021.107956","type":"journal-article","created":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T04:20:12Z","timestamp":1626582012000},"page":"107956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Alisol B 23-acetate, a new promoter for cholesterol efflux from dendritic cells, alleviates dyslipidemia and inflammation in advanced atherosclerotic mice"],"prefix":"10.1016","volume":"99","author":[{"given":"Yuting","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.intimp.2021.107956_b0005","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","article-title":"Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications","volume":"116","author":"Tabas","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.intimp.2021.107956_b0010","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.intimp.2021.107956_b0015","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.immuni.2017.09.008","article-title":"Monocyte-Macrophages and T Cells in Atherosclerosis","volume":"47","author":"Tabas","year":"2017","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.intimp.2021.107956_b0020","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCRESAHA.114.302761","article-title":"Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis","volume":"114","author":"Ait-Oufella","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2021.107956_b0025","doi-asserted-by":"crossref","first-page":"5946807","DOI":"10.1155\/2016\/5946807","article-title":"Dendritic Cells and Their Role in Cardiovascular Diseases: A View on Human Studies","volume":"2016","author":"Dieterlen","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"9","key":"10.1016\/j.intimp.2021.107956_b0030","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.imbio.2016.05.010","article-title":"Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells","volume":"221","author":"Chistiakov","year":"2016","journal-title":"Immunobiology"},{"issue":"9","key":"10.1016\/j.intimp.2021.107956_b0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003976","article-title":"Oxidized Low-Density Lipoprotein (OxLDL)-Treated Dendritic Cells Promote Activation of T Cells in Human Atherosclerotic Plaque and Blood, Which Is Repressed by Statins: microRNA let-7c Is Integral to the Effect","volume":"5","author":"Frosteg\u00e5rd","year":"2016","journal-title":"J Am Heart Assoc."},{"issue":"11","key":"10.1016\/j.intimp.2021.107956_b0040","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.intimp.2021.107956_b0045","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1172\/JCI44925","article-title":"CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice","volume":"121","author":"Weber","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.intimp.2021.107956_b0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2015.03.002","article-title":"Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer","volume":"21","author":"Bovenga","year":"2015","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.intimp.2021.107956_b0055","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1152\/physrev.00004.2011","article-title":"Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response","volume":"92","author":"Nagy","year":"2012","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2021.107956_b0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1073\/pnas.0135855100","article-title":"Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist","volume":"100","author":"McIntyre","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"19","key":"10.1016\/j.intimp.2021.107956_b0065","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1038\/emboj.2010.197","article-title":"The nuclear receptor PPAR\u03b3 individually responds to serotonin- and fatty acid-metabolites","volume":"29","author":"Waku","year":"2010","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.intimp.2021.107956_b0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(00)81574-3","article-title":"Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma","volume":"93","author":"Nagy","year":"1998","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.intimp.2021.107956_b0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jaci.2013.05.044","article-title":"The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology","volume":"132","author":"Kiss","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107956_b0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.atherosclerosis.2012.07.029","article-title":"HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells","volume":"225","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.intimp.2021.107956_b0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/10826076.2012.668733","article-title":"Optimization of Extraction Condition for Alisol B and Alisol B Acetate in Alismatis Rhizoma using Response Surface Methodology","volume":"36","author":"Lee","year":"2013","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.intimp.2021.107956_b0090","doi-asserted-by":"crossref","first-page":"4753852","DOI":"10.1155\/2016\/4753852","article-title":"The Cholesterol-Lowering Effect of Alisol Acetates Based on HMG-CoA Reductase and Its Molecular Mechanism","volume":"2016","author":"Xu","year":"2016","journal-title":"Evid. Based Complement Alternat. Med."},{"issue":"12","key":"10.1016\/j.intimp.2021.107956_b0095","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.3390\/ijms19124092","article-title":"Alisol B 23-Acetate Inhibits IgE\/Ag-Mediated Mast Cell Activation and Allergic Reaction","volume":"19","author":"Shao","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2021.107956_b0100","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.12659\/MSM.918252","article-title":"Alisol B 23-Acetate Ameliorates Lipopolysaccharide-Induced Cardiac Dysfunction by Suppressing Toll-Like Receptor 4 (TLR4)\/NADPH Oxidase 2 (NOX2) Signaling Pathway","volume":"25","author":"Wang","year":"2019","journal-title":"Med. Sci. Monit."},{"issue":"4","key":"10.1016\/j.intimp.2021.107956_b0105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3892\/ijmm.2014.1646","article-title":"Effects of Alisma Decoction on lipid metabolism and inflammatory response are mediated through the activation of the LXR\u03b1 pathway in macrophage-derived foam cells","volume":"33","author":"Xue","year":"2014","journal-title":"Int. J. Mol Med."},{"issue":"6","key":"10.1016\/j.intimp.2021.107956_b0110","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.cmet.2017.04.005","article-title":"Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity","volume":"25","author":"Westerterp","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2021.107956_b0115","article-title":"Insulin increases cholesterol uptake, lipid droplet content, and apolipoprotein B secretion in CaCo-2 cells by upregulating SR-BI via a PI3K, AKT, and mTOR-dependent pathway","author":"Fuentes","year":"2018","journal-title":"J. Cell Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2021.107956_b0120","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bcp.2012.12.024","article-title":"Knock-down of the oxysterol receptor LXR\u03b1 impairs cholesterol efflux in human primary macrophages: lack of compensation by LXR\u03b2 activation","volume":"86","author":"Ishibashi","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107956_b0125","doi-asserted-by":"crossref","first-page":"2531979","DOI":"10.1155\/2019\/2531979","article-title":"Yangyin Qingre Huoxue Method in Traditional Chinese Medicine Ameliorates Atherosclerosis in ApoE-\/- Mice Suffering from High-Fat Diet and HSP65 Aggression","volume":"2019","author":"Qiu","year":"2019","journal-title":"Evid. Based Complement Alternat. Med."},{"key":"10.1016\/j.intimp.2021.107956_b0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12986-020-00461-z","article-title":"Resveratrol ameliorates atherosclerosis induced by high-fat diet and LPS in ApoE-\/- mice and inhibits the activation of CD4+ T cells","volume":"17","author":"Zhou","year":"2020","journal-title":"Nutr. Metab. (Lond)."},{"issue":"1","key":"10.1016\/j.intimp.2021.107956_b0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/aps.2016.119","article-title":"Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation","volume":"38","author":"Meng","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.intimp.2021.107956_b0140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1152\/physrev.00025.2005","article-title":"Transcriptional regulation of metabolism","volume":"86","author":"Desvergne","year":"2006","journal-title":"Physiol. Rev."},{"issue":"1\u20135","key":"10.1016\/j.intimp.2021.107956_b0145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jsbmb.2004.03.013","article-title":"Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands","volume":"89\u201390","author":"Adorini","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.intimp.2021.107956_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108464","article-title":"The effects of 1,25-dihydroxyvitamin D3 on markers related to the differentiation and maturation of bone marrow-derived dendritic cells from control and obese mice","volume":"85","author":"Cha","year":"2020","journal-title":"J. Nutr. Biochem."},{"issue":"6","key":"10.1016\/j.intimp.2021.107956_b0155","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1194\/jlr.M800597-JLR200","article-title":"Sodium taurocholate-dependent lipid efflux by ABCA1: effects of W590S mutation on lipid translocation and apolipoprotein A-I dissociation","volume":"50","author":"Nagao","year":"2009","journal-title":"J. Lipid Res."},{"issue":"20","key":"10.1016\/j.intimp.2021.107956_b0160","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00018-013-1289-1","article-title":"Inflammation and immune system interactions in atherosclerosis","volume":"70","author":"Legein","year":"2013","journal-title":"Cell Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.intimp.2021.107956_b0165","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028613","article-title":"Development, Diversity, and Function of Dendritic Cells in Mouse and Human","volume":"10","author":"Anderson","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.intimp.2021.107956_b0170","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.coph.2014.07.013","article-title":"Modulation of dendritic cell antigen presentation by pathogens, tissue damage and secondary inflammatory signals","volume":"17","author":"Vega-Ramos","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2021.107956_b0175","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.5604\/01.3001.0010.5495","article-title":"Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport","volume":"16","author":"Wang","year":"2017","journal-title":"Ann. Hepatol."},{"issue":"17","key":"10.1016\/j.intimp.2021.107956_b0180","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/eurheartj\/ehi282","article-title":"Dendritic cells in atherosclerosis: current status of the problem and clinical relevance","volume":"26","author":"Bobryshev","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.intimp.2021.107956_b0185","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis (*)","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2021.107956_b0190","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/CIRCRESAHA.108.185793","article-title":"CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis","volume":"103","author":"Packard","year":"2008","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.intimp.2021.107956_b0195","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.4049\/jimmunol.1402870","article-title":"High-density lipoprotein attenuates Th1 and th17 autoimmune responses by modulating dendritic cell maturation and function","volume":"194","author":"Tiniakou","year":"2015","journal-title":"J. Immunol."},{"issue":"34","key":"10.1016\/j.intimp.2021.107956_b0200","doi-asserted-by":"crossref","first-page":"25123","DOI":"10.1074\/jbc.M704590200","article-title":"Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles","volume":"282","author":"Vedhachalam","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"35","key":"10.1016\/j.intimp.2021.107956_b0205","doi-asserted-by":"crossref","first-page":"24020","DOI":"10.1074\/jbc.R114.583658","article-title":"Molecular mechanisms of cellular cholesterol efflux","volume":"289","author":"Phillips","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2021.107956_b0210","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.RES.0000250171.54048.5c","article-title":"ATP-Binding cassette cholesterol transporters and cardiovascular disease","volume":"99","author":"Oram","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2021.107956_b0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fimmu.2014.00007","article-title":"Regulatory dendritic cells for immunotherapy in immunologic diseases","volume":"5","author":"Gordon","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2021.107956_b0220","doi-asserted-by":"crossref","first-page":"2636701","DOI":"10.1155\/2016\/2636701","article-title":"Metabolism Is Central to Tolerogenic Dendritic Cell Function","volume":"2016","author":"Sim","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"6917","key":"10.1016\/j.intimp.2021.107956_b0225","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2021.107956_b0230","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri2675","article-title":"Macrophage death and defective inflammation resolution in atherosclerosis","volume":"10","author":"Tabas","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2021.107956_b0235","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.intimp.2021.107956_b0240","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.immuni.2016.11.008","article-title":"Cholesterol Accumulation in CD11c+ Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease","volume":"45","author":"Ito","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2021.107956_b0245","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.immuni.2004.09.003","article-title":"Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization","volume":"21","author":"Angeli","year":"2004","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2021.107956_b0250","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-2007-990278","article-title":"Reduced frequency of peripheral dendritic cells in type 2 diabetes","volume":"116","author":"Seifarth","year":"2008","journal-title":"Exp. Clin. Endocrinol. Diabetes."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:13:37Z","timestamp":1730837617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921005920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"alternative-id":["S1567576921005920"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107956","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alisol B 23-acetate, a new promoter for cholesterol efflux from dendritic cells, alleviates dyslipidemia and inflammation in advanced atherosclerotic mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107956"}}